Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
50,896,394
-
Share change
-
+239,121
-
Total reported value
-
$6,124,009,590
-
Put/Call ratio
-
199%
-
Price per share
-
$120.34
-
Number of holders
-
253
-
Value change
-
+$58,035,871
-
Number of buys
-
117
-
Number of sells
-
148
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2019
As of 30 Jun 2019 HAEMONETICS CORP - Common Stock (HAE) had 253 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 50,896,394 shares of stock of the company.
Largest 10 holders included BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Capital Research Global Investors, RENAISSANCE TECHNOLOGIES LLC, Neuberger Berman Group LLC, Jackson Square Partners, LLC, STATE STREET CORP, WELLS FARGO & COMPANY/MN, and FRANKLIN RESOURCES INC.
This table shows 253 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.